Catherine Thieblemont: Reappointed as Head of Department – A Joy, A Responsibility, and A Challenge that Remains Intact
Catherine Thieblemont, Head of the Hematology-Oncology Department – University of Paris; APHP, Saint-Louis Hospital, shared on LinkedIn:
”Reappointed as Head of Department: a joy, a responsibility, and a challenge that remains intact.
Today, Guillaume du Chaffaut of the APHP.Nord University Hospital Group and Prof. Anne Couvelard, Medical Director of the APHP.
Nord, have just formalized my renewal as head of the Hematology-Oncology Department at Saint-Louis Hospital, with the support of Prof. Sabine Sarnacki, Dean of the Faculty of Medicine at universitepariscite.fr.
This vote of confidence from three leading figures at AP-HP and the University is a tribute to our discipline, our hospital, and all the work we have accomplished over so many years.
After 17 years in leadership, being reappointed is never an “automatic” gesture.
On the contrary, it is a clear invitation to continue to uphold innovation, scientific excellence, and humanity in care: the three pillars that have defined our department since day one.
I am also well aware that this responsibility is even more demanding for a woman (as so many studies show!).
Despite the changes in our society, the challenges are real (isn’t that right, Women in Lymphoma?).
But I have been fortunate to move forward, surrounded by women of great value, some of whom are still by my side, and a close-knit, enthusiastic, and extraordinarily committed paramedical team.
Nothing we have built would have been possible without them.
In this context, preparing for the future is a major challenge.
Ensuring a solid succession is a demanding, almost intimate responsibility, as a department represents a real home that is being passed on.
It is to this essential task that I wish to devote the coming year in particular.
For many years, our department has welcomed and trained young doctors, several of whom are now in a position to gradually take on new responsibilities.
I am thinking in particular of Dr. Côme Bommier, whose expertise in the field of lymphoma is widely recognized.
He also possesses a rare quality: that of bringing people together.
He brings people together around concrete projects that directly benefit our patients—sports and health, supportive care, continuity between city and hospital—and around issues that are essential for caregivers—medical ethics, burnout prevention, collective reflection on end-of-life care.
He will also be able to bring people together around the assessment of the carbon footprint of our treatments, thus incorporating the OneHealth approach.
Seeing these dynamics emerge today confirms to me that those years had profound meaning.
Our patients’ prognosis has changed, their care pathways have been enriched, and a new generation is ready to take up the torch without compromising our standards.
The work continues—with humility, energy, and immense gratitude to those who have accompanied me for 17 years.”
Stay updated with Hemostasis Today.
-
Dec 2, 2025, 11:22Habib Bennaceur: Novo Nordisk Completed its Acquisition of Zaltenibart from Omeros Corporation
-
Dec 2, 2025, 11:14Amanda Farrin on Rustam Al-Shahi Salman’s Call to Arms: Great Messaging for the Opening Plenary at UKSF25
-
Dec 2, 2025, 10:06Maeva May Shares Stroke Association’s New Research Strategy that Launched at UKSF2025
-
Dec 2, 2025, 10:00Jennifer Ficenec: What Happens to Blood Products After Hospitals Say No?
-
Dec 2, 2025, 09:55Marilena Vrana Reflects on A Year of Growth, Gratitude, and Collective Strength
-
Dec 2, 2025, 09:51Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
-
Dec 2, 2025, 09:51Arsène Mekinian: Corticosteroid Tapering Strategies Show No Difference
-
Dec 2, 2025, 09:50Joanna Sadowska: Bayer’s Asundexian Reduces Ischemic Stroke Risk in Phase 3 Trial
-
Dec 2, 2025, 09:49George Touma: Sirolimus DCBs Will Eventually Replace Paclitaxel